These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30645170)

  • 21. Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy.
    Mendes de Almeida R; Tavares J; Martins S; Carvalho T; Enguita FJ; Brito D; Carmo-Fonseca M; Lopes LR
    PLoS One; 2017; 12(8):e0182946. PubMed ID: 28797094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reevaluation of the South Asian
    Harper AR; Bowman M; Hayesmoore JBG; Sage H; Salatino S; Blair E; Campbell C; Currie B; Goel A; McGuire K; Ormondroyd E; Sergeant K; Waring A; Woodley J; Kramer CM; Neubauer S; Farrall M; Watkins H; Thomson KL;
    Circ Genom Precis Med; 2020 Jun; 13(3):e002783. PubMed ID: 32163302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homozygosity for a novel splice site mutation in the cardiac myosin-binding protein C gene causes severe neonatal hypertrophic cardiomyopathy.
    Xin B; Puffenberger E; Tumbush J; Bockoven JR; Wang H
    Am J Med Genet A; 2007 Nov; 143A(22):2662-7. PubMed ID: 17937428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two novel mutations of the MYBPC3 gene identified in Chinese families with hypertrophic cardiomyopathy.
    Lin J; Zheng DD; Tao Q; Yang JH; Jiang WP; Yang XJ; Song JP; Jiang TB; Li X
    Can J Cardiol; 2010 Dec; 26(10):518-22. PubMed ID: 21165360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum of MYBPC3 Gene Mutations in Patients with Hypertrophic Cardiomyopathy, Reporting Two Novel Mutations from North-West of Iran.
    Emrahi L; Tabrizi MT; Gharehsouran J; Ardebili SM; Estiar MA
    Clin Lab; 2016; 62(5):757-64. PubMed ID: 27348999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial and Functional Distribution of
    Helms AS; Thompson AD; Glazier AA; Hafeez N; Kabani S; Rodriguez J; Yob JM; Woolcock H; Mazzarotto F; Lakdawala NK; Wittekind SG; Pereira AC; Jacoby DL; Colan SD; Ashley EA; Saberi S; Ware JS; Ingles J; Semsarian C; Michels M; Olivotto I; Ho CY; Day SM
    Circ Genom Precis Med; 2020 Oct; 13(5):396-405. PubMed ID: 32841044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Variants and Mutational Analyses of Cardiac Myosin-binding Protein C (MYBPC3) Gene of Adult Bangladeshi Patients with Hypertrophic Cardiomyopathy.
    Banu LA; Masum MM; Rahman S; Mahbuba S; Hossain M; Hosen MJ; Banerjee SK; Adhikary DK; Habib SA; Sultana GN; Islam MN
    Mymensingh Med J; 2023 Apr; 32(2):520-526. PubMed ID: 37002766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SEPT-GD: A decision tree to prioritise potential RNA splice variants in cardiomyopathy genes for functional splicing assays in diagnostics.
    Alimohamed MZ; Boven LG; van Dijk KK; Vos YJ; Hoedemaekers YM; van der Zwaag PA; Sijmons RH; Jongbloed JDH; Sikkema-Raddatz B; Westers H
    Gene; 2023 Jan; 851():146984. PubMed ID: 36270459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of known feline MYH7 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy.
    O'Donnell K; Adin D; Atkins CE; DeFrancesco T; Keene BW; Tou S; Meurs KM
    Anim Genet; 2021 Aug; 52(4):542-544. PubMed ID: 33970514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
    Marston S; Copeland O; Gehmlich K; Schlossarek S; Carrier L
    J Muscle Res Cell Motil; 2012 May; 33(1):75-80. PubMed ID: 22057632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Groeneweg JA; Ummels A; Mulder M; Bikker H; van der Smagt JJ; van Mil AM; Homfray T; Post JG; Elvan A; van der Heijden JF; Houweling AC; Jongbloed JD; Wilde AA; van Tintelen JP; Hauer RN; Dooijes D
    Heart Rhythm; 2014 Nov; 11(11):2010-7. PubMed ID: 25087486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene.
    Lekanne Deprez RH; Muurling-Vlietman JJ; Hruda J; Baars MJ; Wijnaendts LC; Stolte-Dijkstra I; Alders M; van Hagen JM
    J Med Genet; 2006 Oct; 43(10):829-32. PubMed ID: 16679492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The «Amish» NM_000256.3:c.3330+2T>G splice variant in MYBPC3 associated with hypertrophic cardiomyopathy is an ancient Swiss mutation.
    Redin C; Pavlidou DC; Bhuiyan Z; Porretta AP; Monney P; Bedoni N; Maurer F; Sekarski N; Atallah I; Émeline D; Jeanrenaud X; Pruvot E; Fellay J; Superti-Furga A
    Eur J Med Genet; 2022 Dec; 65(12):104627. PubMed ID: 36162733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
    Bagnall RD; Ingles J; Dinger ME; Cowley MJ; Ross SB; Minoche AE; Lal S; Turner C; Colley A; Rajagopalan S; Berman Y; Ronan A; Fatkin D; Semsarian C
    J Am Coll Cardiol; 2018 Jul; 72(4):419-429. PubMed ID: 30025578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.